European Companies Search Engine
EU funding (€1,499,888): Unlocking the scientific excellence and innovation capacity of the University of Aveiro in supramolecular multicomponent biomaterials for enabling advanced biomaterials for … Hor 4 Sept 2022 EU Research and Innovation programme "Horizon"
Text
Unlocking the scientific excellence and innovation capacity of the University of Aveiro in supramolecular multicomponent biomaterials for enabling advanced biomaterials for healthcare
SUPRALIFE addresses current hurdles of UAVR in the supramolecular biomaterials chemistry field regarding its scientific know-how and partnerships with world-leading institutions. UAVR seeks to improve the multifunctionality of biopolymers, often with limited bioactivity, stimuli-responsiveness and mechanical properties, and increase their performance in biomedical applications. Biopolymers integration with self-assembling motifs would enable the development of innovative supramolecular architectures with bioinstructive and adaptive behaviour for enhanced cellular response, drug delivery and diagnosis. SUPRALIFE aims to surpass UAVRs limited knowledge and expertise on non-covalent synthesis by launching an international scientific and training network to accelerate the pace on developing complex and innovative supramolecular multifunctional biomaterials to interface with living systems. The consortium encompasses UAVR and two internationally-leading institutions, TU/e and UBx, that will critically enhance UAVRs scientific excellence, innovation capacity, and reputation in supramolecular chemistry and translational self-assembling biomaterials. UAVRs capability to train highly-qualified researchers and staff will significantly increase, giving rise to a next-generation of specialised professionals with scientific and translational competences. SUPRALIFE proposes the organisation of joint events, networking activities, short-term on-site trainings and staff exchanges, expert visits, and an exploratory research project for stepping up and stimulating UAVR scientific excellence and innovation capacity. Outputs include increasing the track-record and quality level of publications, IP, innovative biomedical products and regional-to-national economic development. SUPRALIFE will empower the establishment of a ground-breaking and long-lasting collaborative consortium for steadily and sustainably pursuing new joint research projects and innovative research lines at UAVR.
Funded Companies:
| Company name | Funding amount |
| Centre National de la Recherche Scientifique CNRS | €0.00 |
| Institut Polytechnique de Bordeaux | €0.00 |
| Technische Universiteit Eindhoven | €246,459 |
| Universidade de Aveiro | €1,011,366 |
| Universite de Bordeaux | €242,063 |
Source: https://cordis.europa.eu/project/id/101079482
The filing refers to a past date, and does not necessarily reflect the current state.